Cerebral Iron Deposition in Neurodegeneration

Petr Dušek(Charles University), Jan Aaseth(Innlandet Hospital Trust)

Biomolecules

May 17, 2022

10.3390/biom12050714

Cited by 149

Related Papers

Arsenic Toxicity: Molecular Targets and Therapeutic Agents

|Biomolecules|2020|249

Trial of Deferiprone in Parkinson’s Disease

|New England Journal of Medicine|2022|220

Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens

|PLoS ONE|2015|102

Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly

|PLoS ONE|2018|102

BRAVE-NET: Fully Automated Arterial Brain Vessel Segmentation in Patients With Cerebrovascular Disease

|Frontiers in Artificial Intelligence|2020|95